Creo is a startup based in the United Kingdom, most recent round Series-c-plus, 2 tracked investors.
Creo is a startup founded in 1999 based in the United Kingdom. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Creo is a medical technology company focused on developing advanced energy solutions for therapeutic endoscopy, including devices that utilize microwave and radiofrequency energy for minimally invasive procedures such as resection, dissection, hemostasis, and ablation in gastrointestinal, pulmonary, hepatic, and pancreatic applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.